Breaking News Headlines Today

News from MedCity News

See all of MedCity News news coverage in one place. Discover how MedCity News’s media bias informs their coverage and compare with thousands of other news outlets.

In total, 343 have been published by MedCity News which Ground News has aggregated in the past 3 months.

MedCity News’s media bias is Center. Ground News assigned this score by aggregating media bias ratings of a Center rating from Ad Fontes Media, a Center rating from Media Bias/Fact Check .

If you want to know if MedCity News is credible or reliable, look no further. We rank MedCity News as High factuality. Find out more about our methodology here.

Information about MedCity News

Where is MedCity News located?MedCity News's Website

Media Bias Ratings

Average Bias Rating:

Center

byAd Fontes Media

Center

byMedia Bias/Fact Check

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top MedCity News News

Business · France

France's Sanofi to acquire biotech firm Vicebio for $1.15 billion

84% Center coverage: 13 sources

French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total of $1.15 billion, expanding its respiratory vaccine portfolio. Following the acquisition, Vicebio's non-mRNA candidate vaccine for treating respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) will be added to Sanofi's range.See the Story

Donald Trump · United States

The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains

50% Center coverage: 12 sources

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S. Untangling the sprawling, global supply chain will be complicated and expensive, and could inadvertently compete with other administration goals regarding drug pricing and availability. The post The Myth of All-American Drugs and What Trump’s Tariffs Miss About Pharma Supply Chains appeared first on MedCity News.See the Story

Duluth, Minnesota · Duluth

Sentara Health Scales Its Use of Regard’s AI Following Strong ROI & Clinician Adoption

100% Center coverage: 1 sources

Sentara Health has rolled out Regard’s AI-powered chart review and discharge summary tool across all 12 of its hospitals. The tool has delivered consistent benefits when it comes to patient safety and documentation accuracy, said Joseph Evans, Sentara’s chief health information officer. The post Sentara Health Scales Its Use of Regard’s AI Following Strong ROI & Clinician Adoption appeared first on MedCity News.Artificial Intelligence · Norfolk Read Article

Microplastics and Our Health: What Does the Science Say?

100% Center coverage: 1 sources

The actual science is far from the apocalyptic scenario we've been led to believe and demonstrates clearly that much of the media rhetoric is rooted far more in fear than in fact.Science Read Article

Why Healthcare Needs Product Marketers: Bridging the Gap Between Access and Sustained Engagement

100% Center coverage: 1 sources

Healthcare is evolving; the way we communicate about it should evolve too. Access alone is not enough. For digital tools and health interventions to make a real impact, people need to feel connected, motivated, and supported over time. The post Why Healthcare Needs Product Marketers: Bridging the Gap Between Access and Sustained Engagement appeared first on MedCity News.Healthcare Read Article

The Digital Supplement Mess: Are We Sacrificing Patient Safety for Clickthrough Rates?

100% Center coverage: 1 sources

Healthcare CEOs and founders, it’s time to step up. We need greater oversight and transparency in the digital supplement space to protect consumers from harm. The post The Digital Supplement Mess: Are We Sacrificing Patient Safety for Clickthrough Rates? appeared first on MedCity News.United States · United States Read Article

Over 200 Organizations Call on DEA to Continue Remote Prescribing of Controlled Substances

100% Center coverage: 2 sources

The Alliance for Connected Care, the American Telemedicine Association and numerous other organizations sent a letter to the DEA urging action to safeguard remote prescribing of controlled substances. The post Over 200 Organizations Call on DEA to Continue Remote Prescribing of Controlled Substances appeared first on MedCity News.DEA · United States See the Story

What Pharma Needs To Get Right About Privacy In The AI Age

100% Center coverage: 1 sources

Leaders in pharma’s AI age won’t be remembered for moving the fastest, but for earning and keeping trust along the way. Privacy will determine which companies pull ahead and which fall behind, making it one of the industry’s biggest tests. The post What Pharma Needs To Get Right About Privacy In The AI Age appeared first on MedCity News.Privacy See the Story

News from MedCity News